Niagen Bioscience Inc (NAGE)

EBITDA Margin

14.19%

TTM · Period ending:

NAGE logo

NAGE EBITDA Margin

Latest reported14.19%
NAGE TTM EBITDA Margin (-53.11% → 14.19%)
High-resolution chart · PNG

NAGE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Niagen Bioscience Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
14.1923%
16.2879%
15.1766%
18.196%
17.0047%
14.8622%
10.3808%
3.2552%
0.2676%
-2.2521%
-3.8686%
-8.1492%
-8.4188%
-14.2514%
-23.2394%
-27.0269%
-38.362%
-36.6655%
-37.7278%
-40.2318%
-34.8332%
-33.1806%
-30.9516%
-37.1839%
-43.4969%
-53.9634%
-64.3257%
-69.2777%
-81.2943%
-91.6434%
-102.4495%
-109.6793%
-98.427%
-91.2328%
-73.8681%
-46.8961%
-40.1683%
-18.2346%
-7.0016%
-3.8912%
0.5027%
-1.8391%
-8.2672%
-7.7642%
-12.8906%
-22.9702%
-32.4624%
-34.0666%
-43.0551%
-41.8597%
-40.5029%
-44.9395%
-43.7374%
-68.1249%
-97.2109%
-121.977%
-159.7056%
-146.1263%
-92.0217%
-70.3771%
-53.818%
-34.3927%
-21.5393%
-12.0253%
-2.2241%
-2.3145%
-8.6231%
-18.7497%
-30.5628%
-40.418%
-51.0522%
-54.4918%
-53.1099%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.